Canary Foundation

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

Martin Köbel, Steve E. Kalloger, Niki Boyd et al. · PLoS Medicine · 2008 · 820 citations · Full text

Medicine, Oncology, Pathology +17

The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection

Patrick O. Brown, Chana Palmer · PLoS Medicine · 2009 · 250 citations · Full text

Medicine, Gynecology, Oncology +17

Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized

Jesse K. McKenney, Wei Wei, Sarah T. Hawley et al. · The American Journal of Surgical Pathology · 2016 · 132 citations

Medicine, Oncology, Pathology +17

The Potential Impact of Reproducibility of Gleason Grading in Men With Early Stage Prostate Cancer Managed by Active Surveillance: A Multi-Institutional Study

Jesse K. McKenney, Jeff Simko, Michael Bonham et al. · The Journal of Urology · 2011 · 109 citations

Medicine, Pathology, Urology +13

DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines

Sahar Houshdaran, Sarah T. Hawley, Chana Palmer et al. · PLoS ONE · 2010 · 103 citations · Full text

Medicine, Molecular Biology, Oncology +16